Vertex Summer Internship, Research - Boston, MA

Vertex Pharmaceuticals

Dec 16, 2023

Applications are closed

Internship
Full-time
Summer Internship
Research & Development
Science
Boston

Requirements

Legally authorized to work in the United States
Enrolled in an undergraduate or graduate program
Majors in the following backgrounds: Biochemistry, Molecular Biology, Biophysics, Cell Biology, Cell Physiology, Chemistry, Pharmacology, Genetics, or a related field of study.
Candidate must be enrolled in an advanced degree program if graduating Spring 2024

Responsibilities

Discovery Research is at the core of Vertex’s ability to push the science of possibility – and our pursuit of breakthrough discoveries has us seeking innovation both internally and externally. In addition to continuously seeking the best and brightest research scientists to join our team, Vertex places a great emphasis on building collaborative relationships.
Analytical Development: works to bring medical discoveries to patients and physicians, translating molecular designs and candidate medicine molecules into manufacturable pharmaceutical materials and medicine products that could be delivered to patients.
Discovery Core: assay execution support, culture and scale up of recombinant and primary human cells
Drug Metabolism & Pharmacokinetics: unites key translational disciplines to mitigate risk and increase the probability of successful clinical development
Human Assay Technologies: supporting human cell assay development such as various 2D and 3D patient-derived cell/ tissue models to build a functional assay for drug discovery.
Vector Core Intern will learn bioprocessing of viral vectors and assist scientific staff in the process development and production of viral vectors, to deliver AAV materials to support programs across the Vertex Cell and Genetic Therapies (VCGT) portfolio of programs.

Vertex Pharmaceuticals

The Science of Possibility

Science & Healthcare

Industry

1001-5000

Employees

1989

Founded Year

Mission & Purpose

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.